Researchers identifies a slight statistical association between GLP-1 receptor agonists (including semaglutide and tirzepatide) and an increased risk of ischemic optic neuropathy.
Trending
- Midday Interview: Quadasia Love newly crowned Ms. World Universal
- Storms today, then the heat turns up as sunshine takes over
- Ludwick’s Garage Turns Dilapidated Junk Into Cool Cruisers
- OpenAI’s new flagship model deletes files on its own, people keep warning
- OpenAI pushes back on Apple trade secret lawsuit
- OpenAI’s first hardware device is reportedly a screenless speaker that can move
- The UK Is Planning a Social Media Curfew for 16- and 17-Year-Olds
- Geoff Cameron lauds Rodri’s performance after Spain beats France | SportsCenter
